Footnotes

• Correction notice This article has been corrected since it published Online First. The provenance and peer review statement has been included.

• Contributors The article was drafted by RL and ES before being reviewed and edited by PMI and MAS.

• Funding The authors have not declared a specific grant for this research from any funding agency in the public, commercial or not-for-profit sectors.

• Competing interests RL received educational grants from Ferring, Pfizer and Vifor Pharma. ES served as a speaker for Pharmacosmos. PMI served as a speaker, a consultant and/or an advisory board member for Abbvie, Warner Chilcott, Ferring, Falk Pharma, Takeda, MSD, Johnson and Johnson, Shire, Vifor Pharma, Pharmacosmos, Topivert, Genentech, Hospira, Samsung Bioepis, and has received research funding from MSD, Takeda and Pfizer. MAS served as a speaker, a consultant and/or an advisory board member for Sandoz, Janssen, Takeda, MSD, Falk and Samsung Bioepis.

• Provenance and peer review Commissioned; externally peer reviewed.